Colvard-Kandavel Eye Center — Encino, California

Colvard-Kandavel Eye Center is a clinical research site located in Encino, California, United States 91316.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Colvard-Kandavel Eye Center has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Cataract, Astigmatism, Dry Eye Disease (DED).

Sponsors: Colvard Kandavel Eye Center, Shammas Eye Medical Center.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Encino

Browse all research sites in California · View every site in Encino

• The University of California, Los Angeles
• Encino Hospital Medical Center
• The Retina Partners
• Pharmacology Research Institute
• Research Site
• Encino Research Center
• Novo Nordisk Investigational Site
• T Joseph Raoof Md Inc
• WR-PRI
• HRC Fertility
• Pfizer Investigational Site
• Clinical Research Site

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Colvard-Kandavel Eye Center?

Colvard-Kandavel Eye Center has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Colvard-Kandavel Eye Center conducted?

Colvard-Kandavel Eye Center has 4 clinical trials on record, with 2 currently active. Their work covers Cataract, Astigmatism, Dry Eye Disease (DED).

Is Colvard-Kandavel Eye Center accredited by Crixeo Clinical Trials?

Colvard-Kandavel Eye Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Colvard-Kandavel Eye Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.